Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Perspective

Published on 24 Aug 2023

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

in Pharmacology of Infectious Diseases

Ke-Wei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228548

5,333 views
14 citations

Original Research

Published on 15 Aug 2023

Bryum billardieri Schwaegr. against EV71 infection: in vitro and in vivo antiviral effects, identification of molecular mechanisms and active monomers

in Pharmacology of Infectious Diseases

Yun-Yu Wang
Qian Li
Xiu-Wei Han
Xin-Huan Wan
Li Zhang
Feng-Jv Niu
Yi-Zhou Xin
Chang-Zheng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164784

2,825 views
1 citation

Original Research

Published on 08 Aug 2023

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

in Pharmacology of Infectious Diseases

Nageh Ahmed El-Mahdy
Sabry Abou-Saif
Medhat Ismail Abd EL hamid
Heba M. Hashem
Mohamed Anwar Hammad
Sally El-Sayed Abu-Risha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128016

2,477 views

Review

Published on 31 Jul 2023

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

in Pharmacology of Infectious Diseases

Binbin Xia
Li Zheng
Yali Li
Wenfang Sun
Yang Liu
Liushui Li
Jingyao Pang
Jing Chen
Jiaxin Li
Hua Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098972

4,671 views
9 citations

Review

Published on 27 Jul 2023

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

in Pharmacology of Infectious Diseases

Exequiel O. J. Porta
Karunakaran Kalesh
Patrick G. Steel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233253

10,133 views
36 citations

Review

Published on 26 Jul 2023

Individualized antibiotic dosage regimens for patients with augmented renal clearance

in Pharmacology of Infectious Diseases

A-Xi Shi
Qiang Qu
Hai-Hui Zhuang
Xin-Qi Teng
Wei-Xin Xu
Yi-Ping Liu
Yi-Wen Xiao
Jian Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137975

13,009 views
27 citations

Perspective

Published on 19 Jul 2023

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents

in Pharmacology of Infectious Diseases

Toshihiko Kakiuchi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216433

3,721 views
3 citations

Brief Research Report

Published on 18 Jul 2023

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

in Pharmacology of Infectious Diseases

Kai Hilpert
Christoph Rumancev
Jurnorain Gani
Dominic W. P. Collis
Paula Matilde Lopez-Perez
Vasil M. Garamus
Ralf Mikut
Axel Rosenhahn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141785

2,618 views
1 citation

Editorial

Published on 13 Jul 2023

Editorial: Reviews in pharmacology of infectious diseases: 2022

in Pharmacology of Infectious Diseases

Hong Zhou
Esther Segal
Linda Boniface Oyama

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236754

1,484 views

Editorial

Published on 13 Jul 2023

Editorial: Global excellence in pharmacology of infectious diseases: Australia and Asia

in Pharmacology of Infectious Diseases

Kwang-sun Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243284

2,743 views

Original Research

Published on 30 Jun 2023

Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study

in Pharmacology of Infectious Diseases

Erlina Burhan
Elisna Syahruddin
Fathiyah Isbaniah
Ginanjar Arum Desianti
Fanny Fachrucha
Cut Yulia Indah Sari
Efriadi Ismail
Puji Astuti
Muhammad Farhan Maruli
Farhan Mubarak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205238

4,293 views
7 citations

Brief Research Report

Published on 28 Jun 2023

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety

in Pharmacology of Infectious Diseases

Andrés Ruiz-Sancho
María Núñez-Núñez
Laura Castelo-Corral
Francisco Javier Martínez-Marcos
Nagore Lois-Martínez
Mohd Hafiz Abdul-Aziz
David Vinuesa-García

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185602

6,413 views
18 citations

Systematic Review

Published on 23 Jun 2023

COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies

in Pharmacology of Infectious Diseases

Hui-Jun Li
Qi-Chao Yang
Yang-Yang Yao
Cheng-Yang Huang
Fu-Qiang Yin
Chen-Yang Xian-Yu
Chao Zhang
Shao-Juan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144824

3,606 views
9 citations

Original Research

Published on 16 Jun 2023

The history of Lyme disease in Italy and its spread in the Italian territory

in Pharmacology of Infectious Diseases

Giusto Trevisan
Maurizio Ruscio
Marina Cinco
Katiuscia Nan
Patrizia Forgione
Nicola Di Meo
Paolo Tranchini
Massimo Nacca
Silvana Trincone
Sara Giordana Rimoldi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128142

10,614 views
11 citations

Editorial

Published on 13 Jun 2023

Editorial: Pharmacology of infectious diseases: world tuberculosis day 2022

in Pharmacology of Infectious Diseases

Shashikant Srivastava
Johannes W. Alffenaar
Sebastian G. Wicha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233347

2,081 views
2 citations

Original Research

Published on 12 Jun 2023

Zika virus-like particles (VLPs) produced in insect cells

in Pharmacology of Infectious Diseases

Renata Gois de Mello
Thaissa Consoni Bernardino
Luis Giovani Oliveira Guardalini
Renato Mancini Astray
Marta Maria Antoniazzi
Simone Gonçalves Silva Jared
Eutimio Gustavo Fernández Núñez
Soraia Attie Calil Jorge

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1181566

5,464 views
8 citations

Review

Published on 12 Jun 2023

Bifunctional antibiotic hybrids: A review of clinical candidates

in Pharmacology of Infectious Diseases

Augustine Jing Jie Koh
Varsha Thombare
Maytham Hussein
Gauri G. Rao
Jian Li
Tony Velkov

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1158152

6,237 views
17 citations

Original Research

Published on 07 Jun 2023

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

in Pharmacology of Infectious Diseases

Lei Zhang
Xinfeng Cai
Fangchen Peng
Shuangshuang Tian
Xinjing Wu
Yun Li
Jinlin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1182644

3,221 views
10 citations

Original Research

Published on 05 Jun 2023

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir

in Pharmacology of Infectious Diseases

Jiantao Zheng
Wencong Hong
Chanjuan Zhou
Donghuang Hong
Hong Yan
Yanghui Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1146938

3,138 views
1 citation

Original Research

Published on 30 May 2023

Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice

in Pharmacology of Infectious Diseases

Shimaa Abd El-Salam El-Sayed
El-Sayed El-Alfy
Mohamed Z. Sayed-Ahmed
Uday Kumar Mohanta
Saad S. Alqahtani
Nawazish Alam
Sarfaraz Ahmad
Md Sajid Ali
Ikuo Igarashi
Mohamed Abdo Rizk

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192999

3,446 views
3 citations

Original Research

Published on 26 May 2023

Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance

in Pharmacology of Infectious Diseases

Ryunha Kim
Rannissa Puspita Jayanti
Hongyeul Lee
Hyun-Kuk Kim
Jiyeon Kang
I-Nae Park
Jehun Kim
Jee Youn Oh
Hyung Woo Kim
Heayon Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1116226

4,581 views
9 citations

Clinical Trial

Published on 23 May 2023

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study

in Pharmacology of Infectious Diseases

Shanshan Li
Xiaojie Wu
Nanyang Li
Guoying Cao
Jingjing Wang
Yuancheng Chen
Size Li
Jinjie He
Jufang Wu
Haijing Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1117293

3,958 views
5 citations

Mini Review

Published on 18 May 2023

An update on the development of novel antifungal agents for eumycetoma

in Pharmacology of Infectious Diseases

David J. Chandler
Alexandro Bonifaz
Wendy W. J. van de Sande

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1165273

6,322 views
10 citations

Original Research

Published on 16 May 2023

Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infection

in Pharmacology of Infectious Diseases

Sha Diao
Zheng Liu
Dan Liu
Xiao Cheng
Linan Zeng
Xue-Feng Jiao
Zhe Chen
Xiaofeng Ni
Siyi He
Bin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161526

3,366 views
3 citations